Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) Study

Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 Association C, 2004 Bardou, 2013, Obesity and colorectal cancer, Gut, 62, 933, 10.1136/gutjnl-2013-304701 Busaidy, 2015, The prevalence and impact of hyperglycemia and hyperlipidemia in patients with advanced cancer receiving combination treatment with the mammalian target of Rapamycin inhibitor Temsirolimus and insulin growth factor-receptor antibody Cixutumumab, Oncologist, 20, 737, 10.1634/theoncologist.2015-0065 Cantiello, 2015, Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review, Int. J. Urol., 22, 22, 10.1111/iju.12644 Chen, 2016, Cancer statistics in China, 2015, CA Cancer J. Clin., 66, 115, 10.3322/caac.21338 Djiogue, 2013, Insulin resistance and cancer: the role of insulin and IGFs, Endocr. Relat. Cancer, 20, R1, 10.1530/ERC-12-0324 Edge, 2010, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM, Ann. Surg. Oncol., 17, 1471, 10.1245/s10434-010-0985-4 Fujita, 2009, Gastric cancer, Lancet, 374, 1593, 10.1016/S0140-6736(09)61946-2 Godsland, 2010, Insulin resistance and hyperinsulinaemia in the development and progression of cancer, Clin. Sci. (Lond.), 118, 315, 10.1042/CS20090399 Grundy, 2004, Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6 Hartgrink, 2009, Gastric cancer, Lancet, 374, 477, 10.1016/S0140-6736(09)60617-6 Hiraki, 2011, Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients, Ann. Surg. Oncol., 18, 3013, 10.1245/s10434-011-1636-0 Hu, 2016, Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: the Fujian prospective investigation of cancer (FIESTA) study, Oncotarget Hu, 2016, The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: the Fujian prospective investigation of cancer (FIESTA) study, Oncotarget Kim, 2014, Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer, Clin. Res. Hepatol. Gastroenterol., 38, 372, 10.1016/j.clinre.2013.11.009 Lin, 2015, Metabolic syndrome and esophageal and gastric cancer, Cancer Causes Control, 26, 1825, 10.1007/s10552-015-0675-4 Lindkvist, 2013, Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the metabolic syndrome and cancer project (me-can), Cancer Causes Control, 24, 107, 10.1007/s10552-012-0096-6 Lv, 2015, Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer, Oncotarget, 6, 9794, 10.18632/oncotarget.3400 Mu, 2012, Insulin resistance: a significant risk factor of endometrial cancer, Gynecol. Oncol., 125, 751, 10.1016/j.ygyno.2012.03.032 Oyama, 2013, Serum cytokeratin 18 as a biomarker for gastric cancer, Clin. Exp. Med., 13, 289, 10.1007/s10238-012-0202-9 Pasanisi, 2006, Metabolic syndrome as a prognostic factor for breast cancer recurrences, Int. J. Cancer, 119, 236, 10.1002/ijc.21812 Peng, 2016, Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study, Int. J. Cancer, 139, 2705, 10.1002/ijc.30404 Perloff, 1993, Human blood pressure determination by sphygmomanometry, Circulation, 88, 2460, 10.1161/01.CIR.88.5.2460 Salisbury, 2015, Insulin/insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies, Front. Endocrinol., 6, 12, 10.3389/fendo.2015.00012 Samani, 2007, The role of the IGF system in cancer growth and metastasis: overview and recent insights, Endocr. Rev., 28, 20, 10.1210/er.2006-0001 Samson, 2014, Metabolic syndrome, Endocrinol. Metab. Clin. N. Am., 43, 1, 10.1016/j.ecl.2013.09.009 Saragoni, 2013, Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification, Gastric Cancer, 16, 549, 10.1007/s10120-013-0233-2 Suda, 2014, The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor, Int. J. Cancer, 135, 1002, 10.1002/ijc.28737 Tiberio, 2015, Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection?, Ann. Surg. Oncol., 22, 589, 10.1245/s10434-014-4018-6 Van Cutsem, 2016, Gastric cancer, Lancet, 10.1016/S0140-6736(16)30354-3 Wei, 2014, Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer, PLoS One, 9, e89965, 10.1371/journal.pone.0089965 Zhang, 2010 Zhang, 2016, Potential biomarkers in diagnosis of human gastric cancer, Cancer Investig., 34, 115, 10.3109/07357907.2015.1114122 Zhu, 2010, Biomarkers of the metabolic syndrome and breast cancer prognosis, Cancer, 2, 721, 10.3390/cancers2020721